Claims
- 1. A method for the treatment or prevention of Alzheimer's disease, in a human, comprising administering to a human in need thereof an effective amount of an agent which results in lowered serum insulin levels.
- 2. The method of claim 1, wherein said agent is chromium.
- 3. The method of claim 1, wherein said agent is insulin-like growth factor.
- 4. The method of claim 1, wherein said agent is a dopamine agonist.
- 5. The method of claim 4, wherein said dopamine agonist is bromocryptine.
- 6. The method of claim 1, wherein said agent is a thiazolidinedione.
- 7. The method of claim 6, wherein said thiazolidinedione is troglitazone.
- 8. A method for the treatment or prevention of Alzheimer's disease, in a human, comprising restricting the metabolizable carbohydrates in the diet of the human to a level which results in lowered serum insulin levels.
- 9. The method of claim 8, wherein the metabolizable carbohydrates in the diet are limited to no more than about 55 grams per day.
- 10. The method of claim 8, wherein the metabolizable carbohydrates in the diet are limited to no more than about 30 grams per day.
- 11. The method of claim 8, wherein the metabolizable carbohydrates in the diet are limited to no more than about 15 grams per day.
- 12. The method of claim 8, wherein the metabolizable carbohydrates in the diet are limited to no more than about 10 grams per day.
- 13. A method for the treatment or prevention of Alzheimer's disease, in a human, comprising administering to a human in need thereof an effective amount of an agent which results in lowered serum insulin levels and restricting the metabolizable carbohydrates in the diet of the human.
- 14. The method of claim 13, wherein said agent is selected from the group consisting of chromium, insulin-like growth factor, a dopamine agonist and a thiazolidinedione.
- 15. The method of claim 13, wherein said agent is troglitazone.
- 16. The method of claim 13, wherein the metabolizable carbohydrates in the diet are limited to no more than about 55 grams per day.
- 17. The method of claim 13, wherein the metabolizable carbohydrates in the diet are limited to no more than about 30 grams per day.
- 18. The method of claim 13, wherein the metabolizable carbohydrates in the diet are limited to no more than about 15 grams per day.
- 19. The method of claim 13, wherein the metabolizable carbohydrates in the diet are limited to no more than about 10 grams per day.
- 20. A method of improving mentation of a patient with Alzheimer's disease, comprising administering to said patient an effective amount of an agent which increases the insulin sensitivity of the patient.
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] The present application is a continuation of PCT/US98/04731 filed Mar. 12, 1998. The present application also claims the benefit of U.S. provisional application 60/039,607. The contents of each of these two applications are fully incorporated by reference herein.
Continuations (2)
|
Number |
Date |
Country |
Parent |
09394712 |
Sep 1999 |
US |
Child |
10669281 |
Sep 2003 |
US |
Parent |
PCT/US98/04731 |
Mar 1998 |
US |
Child |
09394712 |
Sep 1999 |
US |